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ABSTRACT
Background
Interleukin (IL)–32 is a newly described proinflammatory cytokine that seems likely to play a
role in inflammation and host defense. Little is known about the regulation of IL-32 production
by primary cells of the immune system.
Methods and Findings
In the present study, freshly obtained human peripheral blood mononuclear cells were
stimulated with different Toll-like receptor (TLR) agonists, and gene expression and synthesis of
IL-32 was determined. We demonstrate that the TLR4 agonist lipopolysaccharide induces
moderate (4-fold) production of IL-32, whereas agonists of TLR2, TLR3, TLR5, or TLR9, each of
which strongly induced tumor necrosis factor a and IL-6, did not stimulate IL-32 production.
However, the greatest amount of IL-32 was induced by the mycobacteria Mycobacterium
tuberculosis and M. bovis BCG (20-fold over unstimulated cells). IL-32-induced synthesis by
either lipopolysaccharide or mycobacteria remains entirely cell-associated in monocytes;
moreover, steady-state mRNA levels are present in unstimulated monocytes without translation
into IL-32 protein, similar to other cytokines lacking a signal peptide. IL-32 production induced
by M. tuberculosis is dependent on endogenous interferon-c (IFNc); endogenous IFNc is, in turn,
dependent on M. tuberculosis–induced IL-18 via caspase-1.
Conclusions
In conclusion, IL-32 is a cell-associated proinflammatory cytokine, which is specifically
stimulated by mycobacteria through a caspase-1- and IL-18-dependent production of IFNc.
The Editors’ Summary of this article follows the references.
PLoS Medicine | www.plosmedicine.org August 2006 | Volume 3 | Issue 8 | e277 1310
PLoS MEDICINEIntroduction
Interleukin (IL)–32 is a recently described cytokine initially
thought to be a product of T, natural killer, and epithelial
cells. The cytokine exhibits several properties of a classical
proinﬂammatory mediator [1]. For example, IL-32 induces
the production of tumor necrosis factor (TNF) a, IL-8, and
MIP-2 via the activation of NF-KB and p38 MAP kinase [1]. In
addition, maturation of IL-1b through a caspase-1-dependent
mechanism is also a property of IL-32 [2]. These proin-
ﬂammatory effects of IL-32 suggest an important role of IL-
32 in inﬂammation and antibacterial defense.
In macrophages infected with intracellular pathogens,
activation by interferon-c (IFNc) in combination with TNF
is a major effector mechanism of cell-mediated immunity [3].
IFNc induces antimicrobial killing mechanisms in monocytes,
macrophages, and neutrophils, by activating phagocytosis,
stimulating oxygen radical production, and activating the
synthesis of the inducible form of NO [4,5]. The crucial role
of these IFNc properties for host antimicrobial defense has
been demonstrated in patients with defects in either IFNc or
IL-12 receptors [6,7]. These patients have increased suscept-
ibility to intracellular microorganisms such as mycobacteria
and salmonella species [6,7]. Infection with atypical mycbo-
bacteria such as non-tuberculous mycobacteria or Mycobacte-
rium bovis BCG is particularly dangerous in patients lacking
adequate IFNc production and is a main factor determining
the long-term prognosis of these patients [8].
Because of the proinﬂammatory effects of IL-32 and its
induction from epithelial cell lines by IFNc [1], we wanted to
determine whether IL-32 is produced from primary cells of
the immune system in response to stimulation with mycobac-
teria. We investigated the stimulation of IL-32 synthesis by
several agonists of TLR, as well as bacterial pathogens. In the
present study, we also deﬁne the IFNc-dependent pathway of
M. tuberculosis–induced IL-32 from peripheral blood mono-
nuclear cells (PBMCs).
Methods
Reagents and Microorganisms
Synthetic Pam3Cys was purchased from EMC Microcollec-
tions (Tubingen, Germany). Lipopolysaccharide (LPS) (Escher-
ichia coli serotype 055:B5) and poly I:C were purchased from
Sigma Chemical (St. Louis, Missouri, United States). H37Rv
and M. bovis BCG were grown to mid-log phase in
Middlebrook 7H9 liquid medium supplemented with oleic
acid, albumin, dextrose, and catalase (Difco Laboratories,
Sparks, Maryland, United States), washed three times in
sterile saline, and resuspended in RPMI 1640 medium.
Separate culture suspensions were sonicated for 10 min on
ice, in order to obtain noninfective cell lysates. Cultures of
Staphylococcus aureus were grown in basic medium broth (Luria
broth supplemented with 0.1% K2HPO4 and 0.1% glucose),
washed in sterile saline, and resuspended in RPMI 1640
medium, as described above.
Stimulation of Whole Blood Cultures with Mycobacteria
After informed consent, venous blood was drawn from the
antecubital vein of eight healthy volunteers into heparin
tubes. Then 750 ll of either RPMI culture medium or RPMI
containing sonicated M. tuberculosis or BGC (both at a
concentration of 10 lg/ml) was added to 4.0-ml screw cap
cryogenic tubes (Corning, Corning, New York, United
States). Thereafter, 250 ll of freshly obtained heparinized
blood was added to tubes containing stimuli. The tubes were
capped tightly and incubated at 37 8C in an upright position.
After 24 h of incubation, the blood was mixed by rapid
vortex and transferred into 1.5-ml Eppendorf tubes (Brink-
mann Instruments, Westbury, New York, United States).
Triton X-100 (Bio-Rad Laboratories, Hercules, California,
United States) was then added (0.5% ﬁnal concentration)
and the blood mixed until lysed. The lysed blood was stored
at  70 8C until assay. In these whole blood cultures,
intracellular and secreted cytokine concentrations were
determined together, and the results represent ‘‘total’’
cytokine production.
Isolation of PBMCs and Stimulation of Cytokine
Production
The PBMC fraction was obtained by density centrifugation
of blood diluted 1:1 in pyrogen-free saline over Histopaque
(Sigma, St. Louis, Missouri, United States). Cells were washed
twice in saline and suspended in culture medium (RPMI 1640)
supplemented with penicillin (100 U/ml) and streptomycin
(100 lg/ml).
To ﬂat-bottom 96-well plates were added 5310
5 PBMCs in
a 100-ll volume, which was then incubated with either 100 ll
of culture medium (negative control) or 100 ll of the various
stimuli: synthetic Pam3Cys lipopeptide (5 lg/ml), poly I:C (5
lg/ml), E. coli LPS (100 ng/ml), or 1 3 10
7 heat-killed
microorganisms/milliliter of M. tuberculosis, M. bovis BCG, or
S. aureus. Each Toll-like receptor (TLR) ligand, except LPS,
was checked for the presence of LPS in the LAL assay and
found to be negative. After 24 h of incubation at 37 8C,
supernatants were removed in some experiments. Otherwise,
the cells were lysed by 1% Triton X-100 and two cycles of
freeze–thaw. Intracellular and secreted cytokine concentra-
tions were determined together, and the results represent
‘‘total’’ cytokine production. In additional experiments, the
effect of a caspase-1 inhibitor (20 lM of Ac-Tyr-Val-Ala-Asp-
2,6-dimethylbezoyloxymethylketone, YVAD, Alexis Biochem-
icals, San Diego, California, United States), IL-1 receptor
antagonist (IL-1Ra, 10 lg/ml, R&D Systems, Minneapolis,
Minnesota, United States), or IL-18 binding protein (10 lg/ml)
[9] on the M. tuberculosis–induced production of IL-32 was
investigated.
In order to test whether the monocyte or lymphocyte
population was the source of IL-32 after stimulation with
mycobacteria, PBMCs were incubated for 2 h at 37 8C. The
nonadherent cells, transferred into another well, were mostly
lymphocytes, whereas the adherent cells were more than 90%
monocytes. The stimulation of IL-32 by the mycobacteria was
compared between monocytes and lymphocytes.
Production of IL-32 stimulated by mycobacteria was also
investigated in monocyte-derived macrophages and dendritic
cells (DCs). Adherent monocytes were incubated in RPMI for
5 d in the presence of either 20% heat-inactivated human
serum for macrophage differentiation, or a combination of
50 ng/ml GM-CSF (Peprotech, Rocky Hill, New Jersey, United
States) plus 20 ng/ml IL-4 (Peprotech) used for DC differ-
entiation. After 5 d, the cells were washed, and the macro-
phages or DCs were stimulated for an additional 24 h with
either M. tuberculosis or M. bovis BCG.
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IL-32 Induction by M. tuberculosisCytokine Measurements
TNFa, IL-6, and IFNc concentrations were determined by
speciﬁc electrochemiluminescence (ECL) assays, as previously
described [10]. A speciﬁc ECL assay was developed for the
measurement of IL-32. The IgG fraction of polyclonal
antibodies produced in goats against recombinant human
IL-32a was puriﬁed with Econo-Pac (Cooper, Boynton Beach,
Florida, United States). This IgG fraction was then afﬁnity
puriﬁed using IL-32a immobilized on Afﬁ-gel 15 agarose
beads (Bio-Rad Laboratories). One aliquot of the afﬁnity-
puriﬁed anti-IL-32a antibody was labeled with biotin, and
another aliquot with ruthenium according with the manu-
facturer’s instructions (BioVeris, Gaithersburg, Maryland,
United States). A standard curve was constructed using
recombinant human IL-32a (Peprotech). For the assay, 25 ll
of a sample or standard was added to 5-ml polypropylene
tubes (Becton Dickinson, Franklin Lakes, New Jersey, United
States) and incubated with dilutions of the biotinylated and
the ruthenylated antibodies for a total aqueous phase of 100
ll and 25 ll of Dynabeads (BioVeris). After shaking at room
temperature for 4 h, the reaction was terminated with 200 ll
of phosphate-buffered saline (PBS). The electrochemilumi-
nescent signal was measured using an Origen Analyzer
(BioVeris), and the concentrations of IL-32 were calculated
from the standard curve generated for each assay. In over ten
assays, the ECL assay for IL-32 detected from 3 pg/ml to 2,000
pg/ml. Because of the polyclonal nature of the goat antibodies
and the overlapping amino acids of the four IL-32 isoforms,
all isoforms of IL-32 were likely detected in the ECL assay.
RT-PCR for the IL-32 Isoforms
Ten million freshly isolated PBMCs were stimulated with
either culture medium, 100 ng/ml LPS, or 1 3 10
7 heat-killed
M. tuberculosis. After 4 h incubation at 37 8C, total RNA was
extracted in 1 ml of TRIzol reagent (Invitrogen, Carlsbad,
California, United States), an improved single-step RNA
isolation method based on the method described by
Chomczynski and Sacchi [11]. In addition, RNA was also
isolated from an aliquot of freshly obtained PBMCs, without
any culture or stimulation. Thereafter, RNA was precipitated
with isopropanol, washed with 70% ethanol, and dissolved in
water. Isolated RNA was treated with DNase before being
reverse transcribed into complementary DNA using oligo(dT)
primers and MMLV reverse transcriptase. PCR was per-
formed using a Peltier Thermal Cycler-200 (Watertown,
Massachusetts, United States). Primer sequences for the IL-
32 isoforms are presented in Table 1: one set of primers
detected both isoform a and b, whereas two different sets of
primers detected isoforms c and d. GAPDH was used as a
reference gene, for which the primers were 59-GGC AAA TTC
AAC GGC ACA-93 (forward) and 59-GTT AGT GGG GTC
TCG CTC TG-93 (reverse). PCR conditions were as follows: 2
min at 50 8C and 10 min at 95 8C, followed by 30 cycles of PCR
reaction at 94 8C for 45 s, 70 8C for 2 min, and 59 8C for 1 min.
The PCR products were run on 1% agarose gels stained with
ethidium bromide.
Immunostaining
Two distinct methods were used for immunostaining,
confocal microscopy, and optical microscopy. For confocal
microscopy, human PBMCs were isolated and cultured on
eight-chamber glass slides (Nalge Nunc International, Naper-
ville, Illinois, United States) at 37 8C in a humidiﬁed
atmosphere of 5% CO2. After the cells were exposed to
appropriate incubation conditions, they were ﬁxed in 70%
acetone and 30% methanol for 5 min and washed in PBS.
Then the cells were ﬁxed in 4% paraformaldehyde for 10 min
at room temperature and washed with PBS. The ﬁxed cells
were permeabilized in PBS containing 5% donkey normal
serum for 30 min at room temperature. This was followed by
exposure to the primary mouse anti-human IL-32 mono-
clonal IgG1 antibody at 4 8C overnight. As negative control,
mouse IgG1 was used instead of the anti-IL-32 antibody. After
being washed in PBS, the cells were counterstained with the
secondary donkey anti-mouse antibody linked to ﬂuorescein-
labeled Cy3 (1:150, red), wheat germ agglutinin (5 lg/ml,
green for cell surface staining), and AMCA(33342) (50 ll/ml,
blue) for 45 min at room temperature. Then the slides were
mounted with aqueous antiquenching medium. The PBMCs
were examined by digital deconvoluted microscopy.
For optical microscopy, PBMCs were isolated and stimu-
lated for 24 h in the presence of culture medium, LPS (100 ng/
ml), or heat-killed M. tuberculosis (10 lg/ml) using TEFLON-
PFA six-well format culture disks (Savillex, Minnetonka,
Minnesota, United States) to avoid adherence of the PBMCs.
After 24 h, cytospins of the stimulated cells were prepared
and stained with the monoclonal anti-IL-32 antibody (MoAb,
clone 9). The primary antibody (5 mg/ml) was diluted (1:500)
and incubated for 30 min with the tissue sections, followed by
rabbit anti-mouse HRPO (1:200, Dako, Glostrup, Denmark)
for 60 min. The slides were then sequentially incubated with
the chromogen (DAB) reagent for 10 min, counterstained
with Mayer’s hematoxylin, and mounted in permount.
Negative control staining was performed using mouse IgG1
isotype antibody. A Leica (Wetzlar, Germany) microscope
(DMRD model) equipped with a digital camera was used to
prepare the microphotographs.
Statistical Analysis
The human experiments were performed in duplicate with
blood obtained from eight volunteers. The differences
between groups were analyzed by Mann–Whitney U test. The
data are given as means 6 standard error of the mean (SEM).
Results
Stimulation of IL-32 by Mycobactyeria
Whole blood diluted one in four with RPMI was stimulated
with 10 lg/ml heat-killed M. tuberculosis or M. bovis BCG. After
Table 1. Primer Sequences Used in the RT-PCR for the Four
Isoforms of IL-32
Isoform Primer Sequence
a and b Forward 59-CTG AAG GCC CGA ATG CAC CAG-39
Reverse 59-GCA AAG GTG GTG TCA GTA TC-39
c Forward 59-GTA ATG CTC CTC CCT ACT TC-39
Reverse 59-GCA AAG GTG GTG TCA GTA TC-39
d Forward 59-TCT CTG GTG ACA TGA AGA AGC T-39
Reverse 59-GCA AAG GTG GTG TCA GTA TC-39
DOI: 10.1371/journal.pmed.0030277.t001
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IL-32 Induction by M. tuberculosis24 h, there was signiﬁcant stimulation of IL-32 as measured in
the total cell lysate of these cultures (Figure 1A). The level of
IL-32 in the lysates of whole blood cultures without
stimulation was less than 5 pg/ml, whereas M. tuberculosis
and M. bovis BCG increased total IL-32 synthesis over 30-fold.
As shown in Figure 1B, a dose-dependent stimulation of IL-
32 release was observed when freshly isolated PBMCs were
stimulated with M. tuberculosis. Interestingly, LPS also stimu-
lated moderate amounts of IL-32 in PBMCs in a dose-
dependent fashion, but these amounts were clearly lower
than those induced by M. tuberculosis (Figure 1B). In contrast,
stimulation with other TLR agonists such as Pam3Cys (TLR2)
and poly I:C (TLR3) did not induce IL-32, despite incremental
stimulations with concentrations of the stimuli up to 100 lg/
ml (Figure 1C and data not shown). The TLR agonists ﬂagellin
(TLR5) and CpG (TLR9) did not induce IL-32 either (data not
shown). Similarly, stimulation of PBMCs with other heat-
killed microorganisms such as S. aureus (shown in Figure 1C),
Candida albicans, or Aspergillus fumigatus (data not shown) did
not stimulate IL-32 production. In contrast, all the TLR
agonists and microorganisms described above were potent
inducers of IL-6 (Figure 1D) and TNF (not shown) produc-
tion, in ranges similar to those induced by M. tuberculosis or
LPS.
Unlike PBMC cultures, whole blood cultures contain all the
plasma components including antibodies and macromole-
cules such as complement components and anti-proteases.
Whereas PBMCs are composed of 10%–15% monocytes and
mostly lymphocytes, whole blood cultures contain 60%–70%
neutrophils, few monocytes (4%–6%), and about 20%
lymphocytes. When comparing total IL-32 production stimu-
lated with either M. tuberculosis or M. bovis BCG, whole blood
cultures produced 136 pg per million monocytes, whereas in
PBMC cultures, 420 pg were produced per million monocytes.
IL-32 Induced by Inflammatory Stimuli Is a Cell-Associated
Cytokine
When human PBMCs were stimulated with 1 3 10
7
microorganisms/milliliter of heat-killed M. tuberculosis, nearly
all IL-32 measured was found in the cell-associated fraction
and not the supernatant medium (Figure 2A). IL-32 was not
detectable in freshly lysed PBMCs or in PBMCs incubated for
24 h without added stimulants. However, as shown in Figure
2B, steady-state levels of mRNA for IL-32b, IL-32c, and IL-32d
are present in freshly isolated PBMCs without adherence to
culture vessels. Levels of IL-32a are low but present. After 4 h
of incubation with RPMI only, the levels of mRNA coding for
each of the isoforms remained unchanged (Figure 2B). Upon
stimulation with LPS for 24 h, there were markedly increased
levels of IL-32a and IL-32c, but little change in IL-32b and IL-
32d (Figure 2B).
As shown in Figure 3A, immunostaining with a monoclonal
mouse anti-human IL-32 antibody also shows the absence of
Figure 1. Stimulation of IL-32 by Mycobacteria
(A) Whole blood was diluted 1:4 with RPMI and stimulated with 10 lg/ml sonicated M. tuberculosis (MTB) or M. bovis BCG (BCG). Triton X-100 (0.5%) was
added 24 h later, and IL-32 concentration was measured by ECL.
(B) Stimulation of freshly isolated PBMCs with various concentrations of LPS or sonicated M. tuberculosis stimulated IL-32 synthesis in a dose-dependent
manner.
(C and D) Freshly isolated PBMCs were stimulated with TLR4 (LPS, 100 ng/ml), TLR2 (Pam3Cys, 10 lg/ml), TLR3 (poly I:C, 5 lg/ml), M. tuberculosis, M.
bovis BCG, or S. aureus (all at 1310
7 microorganisms/milliliter, heat-killed). After 24 h of stimulation, LPS-, M. tuberculosis–, and M. bovis BCG–stimulated
production of IL-32 (C) or IL-6 (D) was measured by ECL.
Data are presented as means 6 SEM (n ¼ 8).
DOI: 10.1371/journal.pmed.0030277.g001
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IL-32 Induction by M. tuberculosisIL-32 protein in PBMC cultures after 24 h without added
stimulants (Figure 3A, upper lane, and Figure 3B, left panel).
However, IL-32 was present after 24 h of incubation with LPS
(Figure 3A, middle lane) or M. tuberculosis (Figure 3A, lower
lane). In addition, immunohistochemistry of the cytospins
demonstrates that stimulation by LPS or M. tuberculosis
revealed a pattern of IL-32 staining particularly associated
with the cell membrane (Figure 3B, middle and right panels).
Monocytes Are the Source of IL-32, but the Presence of
Lymphocytes Increases IL-32 Production
PBMCs were separated into adherent monocytes, and non-
adherent lymphocytes, which were removed and cultured
separately. When stimulated with M. tuberculosis or M. bovis
BCG, monocytes were the primary source of IL-32, as
demonstrated by the signiﬁcantly higher concentration of
IL-32 in the cell lysates of stimulated monocytes, compared
with the lymphocytes (Figure 4A). However, comparison to
the mixture of monocytes and lymphocytes in unfractionated
PBMCs makes it clear that the presence of lymphocytes
potentiates the stimulation of IL-32 by the monocytes, and
thus contributes signiﬁcantly to the total production of IL-32
(Figure 4A). Each volunteer tested in the present study was
PPD-negative, which rules out the inﬂuence of lymphocytes
due to antigen presentation of mycobacteria to speciﬁc T
cells.
To investigate the production of IL-32 by differentiated
monocytes, freshly obtained blood monocytes were cultured
with 20% human serum to induce macrophage-like cells, or
with a combination of GM-CSF/IL-4 to obtain a DC
population. As shown in Figure 4B, monocyte-derived
macrophages and DCs produced approximately the same
amount of IL-32 as freshly cultured adherent monocytes (see
Figure 4A). This was observed for both M. tuberculosis and M.
bovis BCG stimulation.
IFNc Induces Production of IL-32 in Primary Cells
As shown in Figure 5, PBMCs stimulated with IFNc
induced an 8-fold increase in IL-32. In contrast, IL-1b or
TNFa did not stimulate the production of IL-32 in PBMCs,
although these cytokines (similar to IFNc) are able to induce
IL-32 in epithelial cells [1]. As a control, in the same PBMC
cultures IL-1b and TNFa induced chemokines and IL-6,
whereas IFNc did not (data not shown). Therefore, it appears
that IFNc is a highly selective IL-32-inducing cytokine for
blood monocytes.
We have compared the production of IFNc induced by
the various stimuli used for the induction of IL-32 release.
The highest amounts of IFNc production were stimulated by
M. tuberculosis (987 6 185 pg/ml) and M. bovis BCG (794 6
201 pg/ml), whereas LPS (217 6 44 pg/ml), S. aureus (343 6
101 pg/ml), and C. albicans (197 6 88 pg/ml) induced
moderate amounts of the cytokine. No IFNc production
was induced by Pam3Cys or poly I:C (data not shown). These
data suggest that the induction of IL-32 by mycobacteria
and LPS may be at least in part mediated by endogenous
IFNc release.
In human PBMCs stimulated with heat-killed S. epidermidis
or LPS, IFNc production is dependent on IL-18, since in the
presence of IL-18BP IFNc production is reduced by over 80%
[12]. The role of IL-18 in IFNc production by microbial
products is dependent on processing and release of IL-18 by
caspase-1 [13,14]. As shown in Figure 5B, M. tuberculosis–
induced IFNc production was reduced 80% by the neutral-
ization of endogenous IL-18 by IL-18BP. In contrast, the
production of TNFa was unaffected by the neutralization of
endogenous IL-18 (Figure 5B).
M. tuberculosis Stimulates IL-32 through a Caspase-1/IL-
18/IFNc-Dependent Mechanism
As shown in Figure 6A, the production of IL-32 in PBMCs
stimulated with M. tuberculosis was reduced by 83% in the
presence of the caspase-1 inhibitor. Under these same
conditions IFNc levels were reduced by 77%, but TNFa
production was unaffected by the inhibition of caspase-1. To
determine whether inhibition of caspase-1 was reducing the
activity of endogenous IL-18 or IL-1b, the PBMCs were
stimulated with M. tuberculosis in the presence of their
respective natural inhibitors, IL-18BP and IL-1Ra. As shown
in Figure 6C, blocking IL-1 activity with saturating concen-
trations of IL-1Ra had no effect on the production of IL-32,
IFNc, or TNFa, whereas IL-6 production was reduced by
44% (p , 0.05; data not shown). As expected, in these same
cultures, IL-18BP reduced both IL-32 (92% reduction) and
IFNc (88% reduction), but not TNFa (Figure 6B). Although
we observed that exogenous IFNc induced IL-32 in PBMCs
(Figure 5A), in order to assess whether endogenous IFNc
provided a similar signal, IFNc activity was neutralized with
neutralizing anti-IFNc antibody. Blockade of endogenous
IFNc activity induced by M. tuberculosis strongly inhibited the
production of IL-32 (56% reduction; Figure 6D). Not
unexpectedly, reducing IFNc activity also moderately re-
duced TNFa synthesis, although this reduction did not reach
statistical signiﬁcance (Figure 6D). Collectively, these experi-
ments demonstrate that M. tuberculosis stimulates the
production of IL-32 through a caspase-1/IL-18/IFNc path-
way.
Figure 2. IL-32 Induced by Inflammatory Stimuli Is a Cell-Associated
Cytokine
(A) Human PBMCs were stimulated with 10 lg/ml sonicated M.
tuberculosis. After 24 h, supernatants and cell lysates were assayed for
IL-32 (see Methods).
(B) RT-PCR of the four IL-32 isoforms in freshly lysed PBMCs (lane1),
PBMCs incubated in medium for 4 h (lane 2), stimulated with 100 ng/ml
LPS (lane 3), or with M. tuberculosis (lane 4).
DOI: 10.1371/journal.pmed.0030277.g002
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IL-32 Induction by M. tuberculosisDiscussion
In the present study we demonstrate that mycobacteria
species such as M. tuberculosis or M. bovis BCG are potent
stimuli for the production of the newly described proin-
ﬂammatory cytokine IL-32. Steady-state levels of mRNA for
IL-32 were present in freshly obtained blood PBMCs in the
absence of culture or stimulants in healthy individuals, but
also after 24 h of incubation. LPS and M. tuberculosis increased
steady-state levels of IL-32 mRNA for isoforms a and c of the
cytokine. Although the ability of LPS to induce the synthesis
of IL-32 was moderate (3- to 4-fold increase), the mycobac-
teria M. tuberculosis and M. bovis BCG induced up to a 20-fold
increase in IL-32 synthesis over PBMCs cultured in the
absence of mycobacteria. Furthermore, we demonstrated that
the increase in IL-32 production by mycobacteria is depend-
ent of the proinﬂammatory pathway involving active IL-18
induced by a caspase-1-dependent pathway. However, the
role for IL-18 is primarily the production of IFNc, which in
turn stimulates IL-32. Indeed, neutralization of endogenous
IFNc prevents M. tuberculosis–induced IL-32, and culturing
PBMCs with exogenous IFNc increases IL-32 production 10-
fold. We conclude that IFNc is the ultimate mediator of IL-32
synthesis induced by mycobacteria.
When PBMCs were stimulated with a large variety of TLR
agonists and heat-killed microorganisms, mycobacteria were
the most potent in inducing the synthesis of IL-32 in both
whole blood and freshly isolated PBMCs (Figure 1). Of the
TLR agonists, only the TLR4 stimulus LPS was able to
stimulate moderate production of IL-32 (3- to 4-fold
increase). These data suggest that while LPS/TLR4 interaction
can increase transcription of IL-32 mRNA over that present
in unstimulated cells, a second signal for synthesis is provided
s p e c i ﬁ c a l l yb ym y c o b a c t e r i a for the production of the
protein. The speciﬁcity of IL-32 stimulation by mycobacteria,
but not other microorganisms, is clinically signiﬁcant since
IL-32 is an IFNc-inducible gene, and IFNc pathway defects
are accompanied by an increased susceptibility to infection
with low-virulent mycobacteria [6–8]. This speciﬁcity suggests
a potential role of IFNc-induced IL-32 in the host defense
Figure 3. IL-32 Immunostaining of Human PBMCs Stimulated with LPS or M. tuberculosis
(A) Freshly isolated PBMCs were left to adhere, stimulated with either control medium (first row), LPS (second row), or M. tuberculosis (MTB; third row),
and 24 h later stained for the presence of IL-32. Nuclei were stained with AMCA (blue, left panels), and IL-32 was stained with Cy3 (red, middle panels).
The right panels show the merged pictures with WGA-stained cellular surface (green).The stained cells were examined by digital deconvoluted
microscopy.
(B) PBMCs stimulated with control medium (left panel), LPS (middle panel), or M. tuberculosis (right panel) were stained with an anti-IL-32 monoclonal
antibody and counterstained with Mayer’s hematoxylin for optical microscopy.
DOI: 10.1371/journal.pmed.0030277.g003
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IL-32 Induction by M. tuberculosisagainst mycobacterial infections. The ﬁndings are also
suggestive of a role of IL-32 in mediating some of the
consequences of mycobacterial stimulation. For example, we
have reported that IL-32 synergizes speciﬁcally with the
muramyldipeptide for IL-6 production [2]. The muramyldi-
peptide is the minimal structure able to reproduce the
adjuvant properties of the mycobacterial cell wall, and IL-6
plays a central role in this adjuvant activity [15].
IFNc induces IL-32 in epithelial cells [1], and we have
observed a similar induction in PBMCs. Although other
proinﬂammatory cytokines such as TNF and IL-1b induce IL-
32 in epithelial cells [1], this was not observed in PBMCs
(Figure 4). We investigated whether stimulation of IL-32 by M.
tuberculosis is indeed mediated through synthesis of endoge-
nous IFNc. Although the monocyte is the primary source of
IL-32, lymphocytes are also required for optimal IL-32
synthesis. It is well established that lymphocytes and natural
killer cells are the two main cell populations involved in the
production and release of IFNc [16]. Stimulation of IFNc by
M. tuberculosis was dependent on intermediary production of
endogenous IL-18 (Figure 4), similarly to the stimulation by
other microorganisms [17]. Inhibition of IL-18 processing by
caspase-1, or neutralization of IL-18 by IL-18BP, inhibited
not only IFNc production, but also the induction of IL-32 by
M. tuberculosis. Because caspase-1 also inhibits processing of
pro-IL-1b into an active mature form, it was necessary to
exclude a role for endogenous IL-1b in the effects of the
caspase-1 inhibitor. Unlike for IL-18, blockade of IL-1 by IL-
1Ra had no effect on M. tuberculosis–induced IL-32 produc-
tion. The fact that IL-32 stimulation by M. tuberculosis was
mediated by the release of endogenous IFNc was further
demonstrated by the blockade of IL-32 synthesis by a
neutralizing antibody to IFNc. Thus, the chain of events
leading to stimulation of IL-32 by M. tuberculosis involves
caspase-1-dependent IL-18 from monocytes, which stimulates
production of IFNc from lymphocytes. IFNc, in turn, drives
the translational machinery for IL-32 synthesis in the
monocytes and macrophages.
Steady-state levels of mRNA coding for IL-32b, IL-32c, and
IL-32d are clearly present in freshly obtained PBMCs, whereas
gene expression for IL-32a is barely detectable; importantly,
there is no detectable IL-32 protein in the lysates of these
cells. IL-32 mRNA of isoforms a and c was stimulated by both
LPS and M. tuberculosis, while isoform b was quite strongly
expressed in steady-state unstimulated cells, and was not
further induced by stimulation. In contrast, IL-32 mRNA
isoform d expression was heterogenous, both in terms of basal
steady-state expression and response to stimulation. Even
Figure 4. IL-32 Production by Monocytes, Macrophages, and DCs
(A) PBMCs were incubated for 2 h at 37 8C in 96-well plates, and non-
adherent lymphocytes were transferred to a different well. The total
PBMCs, the adherent monocytes, or the non-adherent lymphocytes were
stimulated with RPMI (hatched bars), M. tuberculosis (open bars), or M.
bovis BCG (solid bars) for an additional 24 h. After 24 h, IL-32
concentrations were measured.
(B) Adherent monocytes were incubated for 5 d with RPMI and 20%
human serum for macrophage differentiation, or a combination of 50 ng/
ml GM-CSF and 20 ng/ml IL-4 for DC differentiation. The macrophages
and DCs were thereafter stimulated for an additional 24 h with RPMI
(hatched bars), M. tuberculosis (open bars), or M. bovis BCG (solid bars). IL-
32 concentration was measured by ECL.
Data are presented as means 6 SEM (n ¼ 8); *, p , 0.05; **, p , 0.01.
DOI: 10.1371/journal.pmed.0030277.g004
Figure 5. IFNc Is a Stimulus of IL-32 Production
(A) PBMCs isolated from five volunteers were stimulated with IFNc, IL-1b,
or TNFa (all at a concentration of 10 ng/ml). IL-32 concentrations were
measured by ECL 24 h later in cells lysed with Triton X-100.
(B) PBMCs were stimulated for 24 h with RPMI, M. tuberculosis (MTB), or
M. tuberculosis in combination with 10 lg/ml IL-18BP. IFNc and TNFa
concentrations were measured 24 h later.
Data are presented as means 6 SEM (n ¼ 5); *, p , 0.05.
DOI: 10.1371/journal.pmed.0030277.g005
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protein in the lysates. However, upon stimulation with LPS
and mycobacteria, IL-32 protein concentration rose 4-fold
and 20-fold, respectively. Since the ECL method for detecting
IL-32 does not distinguish between the different isoforms, the
IL-32 protein in the lysates could be due to any one of the
isoforms.
The dissociated expression of the IL-32 gene and synthesis
of the cytokine itself is reminiscent of the dissociation of IL-
1b gene expression and synthesis in PBMCs. In studies of IL-
1b expression, adherence to glass or plastic in the strict
absence of endotoxins or other microbial agents was
sufﬁcient for IL-1b gene expression, but not for the trans-
lation into the IL-1b precursor [18]. Even using the
inﬂammatory C5a complement component, human PBMCs
exhibit the same levels of IL-1b and TNFa gene expression as
those induced with LPS [19] but, in the case of C5a
stimulation, without detectable translation of IL-1b or TNFa
[19]. In those studies, there was no failure of mRNA coding of
IL-1b to associate with large polysomes and initiate trans-
lation [20]; in fact, evidence revealed that initiation of
translation was intact [20]. However, adherence to glass and
plastic surfaces or stimulation by C5a was not sufﬁcient to
complete the translation into the IL-1b precursor. The failure
to complete translation appeared to be due to early
termination of elongation of the polypeptide [20]. LPS or
IL-1b itself at exceedingly low concentrations provide the
intracellular components to complete the translation [19]. It
is presently unknown whether mRNA coding for IL-32a, IL-
32b, IL-32c, or IL-32d is similarly incapable of completing
translation or whether binding to the ribosome is defective.
However, the data in the present study suggest that unlike
most mRNA coding for cytokines, IL-32 mRNA belongs to the
class of proinﬂammatory cytokines that are regulated unless a
second signal is provided. In addition, stronger IFNc
stimulation by mycobacteria compared to other stimuli could
also have played a role in the differential stimulation of IL-32.
However, IFNc and IL-32 production were not completely
correlated, as some microorganisms such as S. aureus or C.
albicans induced IFNc production, yet they were incapable of
stimulating IL-32 release. In this respect, the release of
intermediary IFNc seems to be a necessary, but not sufﬁcient,
step in the induction of IL-32.
Corroborating these ﬁndings is the absence of IL-32
protein in adherent blood monocytes cultured for 24 h and
examined by immunostaining with an anti-human IL-32
monoclonal antibody. The absence of IL-32 protein employ-
ing either an afﬁnity-puriﬁed goat anti-human IL-32a anti-
body or the monoclonal antibody supports the concept that
IL-32 gene expression can exist without translation into IL-32
protein. The monoclonal antibody’s ability to detect IL-32
was apparent following stimulation with LPS or M. tuberculosis.
There was staining for IL-32 on the cells’ surface and
measurable IL-32 in the lysates of these cells. The staining
of IL-32 in the confocal microscopy was comparable to the
diffuse cytosolic staining patterns seen for IL-1a and IL-1b in
LPS-stimulated monocytes [21]. However, the localized
immunohistochemical staining of the cell membrane after
stimulation with LPS or M. tuberculosis suggests that IL-32 is a
cell-associated cytokine, similar to other cytokines such as IL-
1a or lymphotoxin-a [22,23].
Both IL-32 (all isoforms) and IL-1b lack a classic signal
peptide. Therefore, it is not unexpected that in stimulated
blood monocytes there is no detectable IL-32 in the super-
Figure 6. M. tuberculosis Stimulates IL-32 through a Caspase-1/IL-18/IFNc-Dependent Mechanism
PBMCs were stimulated with RPMI, M. tuberculosis (MTB), or a combination of M. tuberculosis and cytokine inhibitors: 20 lM of a caspase-1 inhibitor
(casp-1inh) (A), 10 lg/ml IL-18BP (B), IL-1Ra (C), or 10 lg/ml of a monoclonal mouse anti-human IFNc antibody (D). As a control for the anti-IFNc
antibody, a similar concentration of a purified mouse IgG1 antibody was used in the control stimulation. After 24 h of incubation, IL-32, IFNc, and TNF
concentrations were measured by ECL. The dashed line represents the 100% stimulation induced by M. tuberculosis alone. The open bars represent the
unstimulated cells, and the solid bars represent the cells stimulated with M. tuberculosis in the presence of the cytokine inhibitors, expressed as percent
of M. tuberculosis production. Data are presented as means 6 SEM (n ¼ 8); *, p , 0.05.
DOI: 10.1371/journal.pmed.0030277.g006
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measurable IL-32. Because LPS and M. tuberculosis stimulate
caspase-1 cleavage of IL-1b, the lack of secreted IL-32 is
consistent with the absence of a caspase-1 site in any of the
isoforms of IL-32. In fact, the decrease in IL-32 synthesis in
the presence of a caspase-1 inhibitor is not a direct effect of
caspase-1 on IL-32 but rather on IL-18-induced IFNc
production. In addition, there is no structural relationship
between members of the IL-1 family and IL-32, also
supporting the absence of caspase-1 cleavage sites in IL-32.
Several cytokines and growth factors lack a clear signal
peptide and are not secreted, but nevertheless play a role in
the pathogenesis of disease. For example, IL-1a is not
secreted from monocytes following stimulation by LPS and
other TLR agonists, despite the presence of large intracellular
s t o r e s .Y e t ,I L - 1 a plays an important role in immune
responses to speciﬁc antigens. Comparing mice deﬁcient in
IL-1a or IL-1b, IL-1a but not IL-1b was required for contact-
allergen-speciﬁc T cell activation during the sensitization
phase in contact hypersensitivity [24]. In addition, macro-
phages of mice deﬁcient in IL-1a display defective phagocy-
tosis and killing of C. albicans, which contributes to their
increased susceptibility to disseminated infections in these
mice (A. G. Vonk, M. G. Netea, J. H. van Krieken, Y. Iwakura,
J. W. van der Meer, et al., unpublished data). Similarly,
membrane-bound TNFa plays an important role in the
pathogenesis of tuberculosis [25]. Another cytokine, acidic
ﬁbroblast growth factor also lacks a signal peptide and is
found primarily in the cytosol. Yet, acidic ﬁbroblast growth
factor plays an important role in neural cell growth [26].
Similarly, although IL-32 appears to be mainly a cell-
associated cytokine, its proinﬂammatory properties suggest
important effects on inﬂammation and host defense.
An important issue relevant to the present study is the
identity of the pattern-recognition receptors that trigger the
translation the of IL-32 mRNA following stimulation with
mycobacteria. The induction of IL-32 by LPS suggests that
TLR4 may be involved, and this is consistent with the studies
showing a role of TLR4 in the recognition of mycobacteria
[27]. However, TLR4 alone is unlikely to be the sole pathway
needed for IL-32 stimulation, given the less efﬁcient
induction of IL-32 by LPS compared with M. tuberculosis and
M. bovis BCG. It is therefore likely that a secondary pathway is
activated by mycobacteria, which is needed in combination
with TLR4 stimulation for the induction of IL-32. Further
studies are needed to elucidate this aspect.
In conclusion, the results of the present study give several
important insights into the biology of IL-32. Firstly,
mycobacteria species induce production of IL-32 from
human monocytes and macrophages, while other micro-
organisms such as S. aureus and the fungal pathogens C.
albicans and A. fumigatus do not. Secondly, this capacity of
mycobacteria to stimulate IL-32 is mediated by their capacity
to induce IFNc, a crucial cytokine of host defense against
these microorganisms. Furthermore, IL-32 is a cell-associated
cytokine, and in this form may exert its proinﬂammatory
effects.
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Editors’ Summary
Background. Tuberculosis (TB) is a serious infectious disease that is
becoming more common. Worldwide it causes around 2 million deaths
every year, mostly in developing countries. Some 2 billion people—or
one-third of the world’s population—are chronically infected without
active symptoms. In humans the disease is usually caused by a bacterium
called Mycobacterium tuberculosis. Another related bacterium, Mycobac-
terium bovis, causes TB in cattle and sometimes in people.
The immune system, which defends the body against infections,
involves a number of cells (for example, the white blood cells) and also
chemicals. People with defects in their immune system are more likely to
suffer from infectious diseases. Cytokines are one class of chemicals in
the immune system. A particular cytokine called interleukin-32 (IL-32) has
been shown to play a role in the development of inflammation, which is
a part of the body’s response to infection. Previous research has
suggested that IL-32 might be of particular importance in the defenses
against TB. In recent years scientists have discovered a lot about the
processes involved in the ‘‘switching on’’ of the individual parts of the
immune system in response to infection. However, very little is known
about the factors influencing the switching on of production of IL-32.
Why Was This Study Done? It would be useful to know more about the
production of IL-32 because it would advance understanding of the
immune system in general and, more specifically, how the body protects
itself against bacteria, such as those that cause TB.
What Did the Researchers Do and Find? Working with eight healthy
volunteers, the researchers took white blood cells of a particular type
(peripheral blood mononuclear cells) and exposed them to substances
known as TLR agonists. Toll-like receptors (TLRs) are receptors on the
surface of leukocytes that recognize specific components of micro-
organisms. Upon recognition of these microbial components, which
function as TLR stimuli (or TLR agonists), signals are transmitted that
activate the immune system and thus the host defense. Using a complex
series of laboratory procedures, they found that one type of TLR agonist
(known as LPS) produced a big increase in IL-32 production, whereas all
the other types of TLR agonists that they used produced only small
increases. The researchers tested M. tuberculosis and M. bovis bacteria to
see whether they increased IL-32 production and they found that they
did so, to a greater degree even than LPS. The researchers also learned
other details about IL-32 and the pathway of chemical changes that
eventually leads to its production.
What Do These Findings Mean? The researchers say their study
provides several important insights into the biology of IL-32. The findings
confirm that IL-32 is an important factor in the body’s defenses against
TB. This information will help in understanding how the disease spreads
and who is most vulnerable to it. Ultimately, it may assist in the search
for new ways of treating and preventing the disease.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0030277.
  The online encyclopedia Wikipedia has useful information on
tuberculosis
  Wikipedia also has useful information on the immune system
  More detailed information about international efforts to control TB
may be found at the Web sites of the International Union Against
Tuberculosis and Lung Disease and the World Health Organization’s
Stop TB Department
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